Caitong International Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,966
Closed -$62.2K 2465
2025
Q3
$62.2K Buy
3,966
+3,247
+452% +$67K 0.04% 260
2025
Q2
$14.3K Buy
719
+350
+95% +$7.1K 0.01% 601
2025
Q1
$6.54K Buy
+369
New +$12K ﹤0.01% 958

Other funds holding TECX

Caitong International Asset Management's TECX Position: Q4 2025 in Review

Caitong International Asset Management sold out of Tectonic Therapeutic (TECX) in Q4 2025, closing a stake of 3,966 shares — an estimated $62.2K sold.

Caitong International Asset Management first reported a position in TECX in Q1 2025 and held it in 3 quarters. The position peaked at $62.2K in Q3 2025. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2025.

  • Caitong International Asset Management reported no remaining Tectonic Therapeutic position as of Q4 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 3,966 Tectonic Therapeutic shares in Q4 2025, an estimated $62.2K.
  • Caitong International Asset Management first reported a position in Tectonic Therapeutic in Q1 2025 and held it in 3 quarters.
  • Caitong International Asset Management's Tectonic Therapeutic position peaked at $62.2K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.